1.Sleep Disturbances and Glucoregulation in Patients with Type 2 Diabetes.
Eun Hee CHO ; Heyjean LEE ; Ohk Hyun RYU ; Moon Gi CHOI ; Sang Wook KIM
Journal of Korean Medical Science 2014;29(2):243-247
We investigated the frequency of sleep disturbances and the association between sleep disturbances and glucoregulation in type 2 diabetic patients. The frequency of sleep disturbances in 614 type 2 diabetic patients was investigated using validated sleep questionnaires. There were 381 male and 233 female patients. The mean age was 59.7 +/- 11.1 yr; the mean body mass index was 24.9 +/- 4.4 kg/m2; the mean HbA1c was 7.8% +/- 1.5%; and the mean duration of diabetes was 10.3 +/- 8.4 yr. The questionnaires revealed insomnia in 48.2% of the patients while 8.5% reported excessive daytime sleepiness. A total of 49% of the patients was poor sleepers, while 28.5% had depression. Multivariate logistic regression analysis showed that there was no significant association between HbA1c and other sleep disturbances, such as poor sleep, insomnia, and short duration of sleep. Sleep disturbances were very common in patients with type 2 diabetes mellitus, whereas there was no association between poor or short sleep and glucoregulation. Awareness and identifying sleep complaints in such patients are necessary to improve their quality of daily life.
Adult
;
Aged
;
Body Mass Index
;
Depression/epidemiology
;
Diabetes Mellitus, Type 2/complications/*diagnosis/drug therapy
;
Female
;
Hemoglobin A, Glycosylated/analysis
;
Humans
;
Hypoglycemic Agents/therapeutic use
;
Logistic Models
;
Male
;
Middle Aged
;
Quality of Life
;
Questionnaires
;
Sleep Disorders/*complications
;
Sleep Initiation and Maintenance Disorders/epidemiology
2.Characteristics of Hypoglycemia Pateints Visiting the Emergency Department of a University Hospital.
Sang Hyeon CHOI ; Deok Ki YOUN ; Moon Gi CHOI ; Ohk Hyun RYU
Journal of Korean Diabetes 2016;17(3):202-211
BACKGROUND: Hypoglycemia is an important obstacle in the treatment of diabetes. When diabetic patients experience hypoglycemia, thorough glycemic control is more difficult. We evaluated the factors associated with risk of hypoglycemia and identified whether the demographic and clinical characteristics or the medication pattern changed during the study period. METHODS: This study was conducted retrospectively with 7 years of data from one university hospital emergency department. We evaluated the medical records of 396 diabetic patients who visited the emergency room with hypoglycemia between January 2008 and December 2014. Hypoglycemia was defined as a serum glucose level less than 70 mg/dL or an event requiring the assistance of another person to actively corrective action. RESULTS: The mean age, duration of diabetes, and hemoglobin A1c (HbA1c) of the study subjects were 71 ± 12.2 years, 12.7 ± 8.8 years, and 6.7 ± 1.39%, respectively. Among the subjects, 55% had a HbA1c level lower than 6.5%. Two-thirds of the study subjects received sulfonylurea, and one-third were treated with insulin. We observed a decreasing trend in the number of hypoglycemia cases during the study period. This trend might be partly explained by the decrease in sulfonylurea use and increase in dipeptidyl peptidase 4 inhibitor prescription during the study period. CONCLUSION: The clinical characteristics of subjects with hypoglycemia were old age, long duration of diabetes, relatively low HbA1c, and comorbidities. We found that hypoglycemia events in diabetic patients decreased in number in conjunction with the changing pattern of use of hypoglycemic agents.
Blood Glucose
;
Comorbidity
;
Diabetes Mellitus
;
Dipeptidyl Peptidase 4
;
Emergencies*
;
Emergency Service, Hospital*
;
Humans
;
Hypoglycemia*
;
Hypoglycemic Agents
;
Insulin
;
Medical Records
;
Prescriptions
;
Retrospective Studies
3.Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes
Hyun-Woong CHO ; Wankyo CHUNG ; Shinje MOON ; Ohk-Hyun RYU ; Min Kyung KIM ; Jun Goo KANG
Diabetes & Metabolism Journal 2020;44(S1):e38-
Background:
This study aimed to assess the effects of sarcopenia and A Body Shape Index (ABSI) on cardiovascular disease (CVD) risk according to obesity phenotypes.
Methods:
We used data from the National Health and Nutrition Examination Survey 1999 to 2012. A total of 25,270 adults were included and classified into the following groups: metabolically healthy normal weight (MHNW), metabolically healthy overweight/obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy overweight/obese (MUO). Sarcopenia was defined as the appendicular skeletal mass index <7 kg/m2 in men and <5.5 kg/m2 in women. A multivariate logistic regression analysis was performed to evaluate the odds ratio (OR) of sarcopenia and ABSI for CVD events according to the obesity phenotype.
Results:
The MHNW participants with sarcopenia had higher risk for CVD than those without sarcopenia (OR, 2.69; 95% confidence interval [CI], 1.56 to 4.64). In the analysis with MHNW participants without sarcopenia as a reference, the participants with sarcopenia showed a higher OR for CVD than those without sarcopenia in both MHO (OR in participants without sarcopenia, 3.31; 95% CI, 1.94 to 5.64) (OR in participants with sarcopenia, 8.59; 95% CI, 2.63 to 28.04) and MUO participants (OR in participants without sarcopenia, 5.11; 95% CI, 3.21 to 8.15) (OR in participants with sarcopenia, 8.12; 95% CI, 4.04 to 16.32). Participants within the second and third tertiles of ABSI had higher ORs for CVDs than the counterpart of obesity phenotypes within the first tertile.
Conclusion
These results suggest that clinical approaches that consider muscle and body shape are required.
4.Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes
Hyun-Woong CHO ; Wankyo CHUNG ; Shinje MOON ; Ohk-Hyun RYU ; Min Kyung KIM ; Jun Goo KANG
Diabetes & Metabolism Journal 2021;45(2):209-218
This study aimed to assess the effects of sarcopenia and A Body Shape Index (ABSI) on cardiovascular disease (CVD) risk according to obesity phenotypes. We used data from the National Health and Nutrition Examination Survey 1999 to 2012. A total of 25,270 adults were included and classified into the following groups: metabolically healthy normal weight (MHNW), metabolically healthy overweight/obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy overweight/obese (MUO). Sarcopenia was defined as the appendicular skeletal mass index <7 kg/m2 in men and <5.5kg/m2 in women. A multivariate logistic regression analysis was performed to evaluate the odds ratio (OR) of sarcopenia and ABSI for CVD events according to the obesity phenotype. The MHNW participants with sarcopenia had higher risk for CVD than those without sarcopenia (OR, 2.69; 95% confidence interval [CI], 1.56 to 4.64). In the analysis with MHNW participants without sarcopenia as a reference, the participants with sarcopenia showed a higher OR for CVD than those without sarcopenia in both MHO (OR in participants without sarcopenia, 3.31; 95% CI, 1.94 to 5.64) (OR in participants with sarcopenia, 8.59; 95% CI, 2.63 to 28.04) and MUO participants (OR in participants without sarcopenia, 5.11; 95% CI, 3.21 to 8.15) (OR in participants with sarcopenia, 8.12; 95% CI, 4.04 to 16.32). Participants within the second and third tertiles of ABSI had higher ORs for CVDs than the counterpart of obesity phenotypes within the first tertile. These results suggest that clinical approaches that consider muscle and body shape are required.
5.Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes
Hyun-Woong CHO ; Wankyo CHUNG ; Shinje MOON ; Ohk-Hyun RYU ; Min Kyung KIM ; Jun Goo KANG
Diabetes & Metabolism Journal 2021;45(2):209-218
This study aimed to assess the effects of sarcopenia and A Body Shape Index (ABSI) on cardiovascular disease (CVD) risk according to obesity phenotypes. We used data from the National Health and Nutrition Examination Survey 1999 to 2012. A total of 25,270 adults were included and classified into the following groups: metabolically healthy normal weight (MHNW), metabolically healthy overweight/obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy overweight/obese (MUO). Sarcopenia was defined as the appendicular skeletal mass index <7 kg/m2 in men and <5.5kg/m2 in women. A multivariate logistic regression analysis was performed to evaluate the odds ratio (OR) of sarcopenia and ABSI for CVD events according to the obesity phenotype. The MHNW participants with sarcopenia had higher risk for CVD than those without sarcopenia (OR, 2.69; 95% confidence interval [CI], 1.56 to 4.64). In the analysis with MHNW participants without sarcopenia as a reference, the participants with sarcopenia showed a higher OR for CVD than those without sarcopenia in both MHO (OR in participants without sarcopenia, 3.31; 95% CI, 1.94 to 5.64) (OR in participants with sarcopenia, 8.59; 95% CI, 2.63 to 28.04) and MUO participants (OR in participants without sarcopenia, 5.11; 95% CI, 3.21 to 8.15) (OR in participants with sarcopenia, 8.12; 95% CI, 4.04 to 16.32). Participants within the second and third tertiles of ABSI had higher ORs for CVDs than the counterpart of obesity phenotypes within the first tertile. These results suggest that clinical approaches that consider muscle and body shape are required.
6.A case of congenital adrenal hyperplasia presenting as adrenal incidentaloma.
Myung Jin CHOI ; Byoung Ho KIM ; Kyoung Min SOHN ; Ha Na YANG ; Ohk Hyun RYU ; Moon Gi CHOI ; Hyung Joon YOO
Korean Journal of Medicine 2009;77(Suppl 1):S103-S108
Congenital adrenal hyperplasia, an autosomal recessive disorder resulting from an enzymatic defect during cortisol biosynthesis (i.e., 21-hydroxylase deficiency), is characterized by impaired production of cortisol with or without impaired production of aldosterone, chronic stimulation of the adrenal cortex by corticotropin, and overproduction of cortisol precursors and androgens. The severity of the hormonal abnormalities and clinical symptoms depend on the degree of enzymatic activity. Phenotypes are classified into the following types: the severe salt-wasting type, the simple virilizing type, and the non-classic type. Despite adequate treatment, patients may be at risk for salt-wasting adrenal crisis, precocious puberty, short stature, infertility, psychosocial problems, and tumor formation, including adrenal incidentaloma. Here we present a case of adrenal incidentaloma in a 14-year-old boy who was eventually diagnosed with congenital adrenal hyperplasia due to a 21-hydroxylase deficiency. The patient had a history of salt-wasting adrenal crisis, but survived without continuous glucocorticoid and mineralocorticoid treatment. Note also that both plasma aldosterone and plasma renin activity were elevated in this case.
Adolescent
;
Adrenal Cortex
;
Adrenal Gland Neoplasms
;
Adrenal Hyperplasia, Congenital
;
Adrenocorticotropic Hormone
;
Aldosterone
;
Androgens
;
Humans
;
Hydrocortisone
;
Infertility
;
Phenotype
;
Plasma
;
Puberty, Precocious
;
Renin
;
Steroid 21-Hydroxylase
7.A Case of Prolonged Coagulopathy in a Patient Intoxicated with Superwarfarin Rodenticide.
Chan Woo PARK ; Jun Hwi CHO ; Joon Ho BAE ; Joong Bum MOON ; Sung Bin CHON ; Ki Ohk AHN ; Hui Young LEE
Journal of The Korean Society of Clinical Toxicology 2011;9(2):113-116
Superwarfarin, such as brodifacoum, is a highly lethal vitamin K antagonist used as a rodenticide. Brodifacoum has a particularly long half-life in the body, which ranges to several months, and therefore requires prolonged treatment with antidotal vitamin K. We experienced a case whereby an 18-year-old male was presented to the hospital with a severe bleeding disorder. It was discovered that he had ingested brodifacoum rodenticide with intent to commit suicide. Despite continual treatment with vitamin K, the bleeding disorder persisted for several months before he recovered. We report this case with literature review.
4-Hydroxycoumarins
;
Adolescent
;
Half-Life
;
Hemorrhage
;
Humans
;
Male
;
Suicide
;
Vitamin K
;
Vitamins
8.Cerebral and Coronary Air Embolism after Percutaneous Needle Aspiration Biopsy of Lung.
Myung Chul SHIN ; Taek Geun OHK ; Jun Hwi CHO ; Joong Beom MOON ; Chan Woo PARK ; Ka Eul KIM ; Go Eun YANG ; Hui Young LEE
Journal of the Korean Society of Emergency Medicine 2017;28(4):395-398
Percutaneous needle aspiration biopsy is a relatively simple and safe procedure for the diagnosis of lung and mediastinal lesions. Systemic air embolism during and after percutaneous needle aspiration biopsy of the lung is very rare; however, it is still a complication that can cause fatal outcomes, such as cerebral infarction and myocardial infarction. Here, we report a 72-year-old woman who suffered a change in consciousness immediately after receiving a percutaneous needle aspiration biopsy for the pathologic examination of pulmonary nodules found during a routine health medical examination. She had left side weakness and ST segment elevation on an electrocardiogram. After a high concentration of oxygen, she recovered from neurological symptoms and electrocardiographic abnormalities. The authors report a case of air embolism occurring simultaneously in the brain and coronary arteries after percutaneous needle aspiration biopsy.
Aged
;
Biopsy
;
Biopsy, Needle*
;
Brain
;
Cerebral Infarction
;
Consciousness
;
Coronary Vessels
;
Diagnosis
;
Electrocardiography
;
Embolism
;
Embolism, Air*
;
Fatal Outcome
;
Female
;
Humans
;
Intracranial Embolism
;
Lung*
;
Myocardial Infarction
;
Needles*
;
Oxygen
9.Pain and Paresthesia after Ingestion of Glechoma Longituba: Three Case Reports.
Chan Woo PARK ; Jun Hwi CHO ; Joon Ho BAE ; Joong Bum MOON ; Seong Bin CHEON ; Ki Ohk AHN ; Hui Young LEE
Journal of the Korean Society of Emergency Medicine 2011;22(4):359-361
Glechoma longituba is a common medicinal plant that is common in wet and sunny land. This plant is used to treat various illnesses including jaundice and edema. But, ingestion of the plant can cause severe pain and swelling on lip and mouth. We experienced three cases that had oral pain and sensory change after ingestion of G. longituba, which we report with a literature review.
Eating
;
Edema
;
Jaundice
;
Lamiaceae
;
Lip
;
Mouth
;
Paresthesia
;
Plants
;
Plants, Medicinal
10.Bursting Fracture of the Thoracic Spine in Ankylosing Spondylitis: No Visible in Standard Radiograph.
Myoung Chul SHIN ; Taek Geun OHK ; Jun Hwi CHO ; Joong Bum MOON ; Chan Woo PARK ; Go Eun YANG ; Min Soo KIM ; Jae Min LEE
Journal of the Korean Society of Emergency Medicine 2016;27(2):206-209
Patients with ankylosing spondylitis (AS) are at high risk for spinal fracture even after a minor injury. Most spinal fractures with ankylosing spondylitis occur in the cervical spine, whereas spinal fractures in thoracic or lumbar spine are rare. These fractures are often difficult to detect on standard radiographs, because the normal anatomical landmarks are lacking and the abnormal spinal stiffness precludes optimal exposure of the spine. We report on a case of a 12th thoracic spine fracture in ankylosing spondylitis with bamboo spine after a minor injury. In this case, anteroposterior and lateral radiographs of the thoracolumbar spine showed a bamboo spine typical for ankylosing spondylitis with no evidence of fracture. However, computed tomography showed a 12th thoracic fracture with burst. Therefore, this fracture, in a patient with AS involved all three spinal columns, was considered unstable.
Humans
;
Spinal Fractures
;
Spine*
;
Spondylitis, Ankylosing*